Radiotherapy and "new" drugs-new side effects? - Wikidata - wikimedia - TriplyDB

Radiotherapy and "new" drugs-new side effects?

Radiotherapy and "new" drugs-new side effects?

http://www.wikidata.org/entity/Q26861498

about

Therapeutic integration of new molecule-targeted therapies with radiotherapy in lung cancer Role of radiotherapy in metastatic non-small cell lung cancer Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.Early onset recall pneumonitis during targeted therapy with sunitinib Helical tomotherapy and systemic targeted therapies in solitary plasmacytoma: Pilot study Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells.Current concepts in clinical radiation oncology.Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism.Cetuximab in non-melanoma skin cancer.To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma.Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology.Anaplastic oligodendroglioma: advances and treatment options.Peripheral nervous system injury after high-dose single-fraction image-guided stereotactic radiosurgery for spine tumors.Application of organ tolerance dose-constraints in clinical studies in radiation oncology.Effects of heat stress on the level of heat shock protein 70 on the surface of hepatocellular carcinoma Hep G2 cells: implications for the treatment of tumors.Inhibitory Effect of Kurarinone on Growth of Human Non-small Cell Lung Cancer: An Experimental Study Both in Vitro and in Vivo Studies.

P2860

Q27004357-063F8369-E3E3-47E4-99A5-172627DB96F8 Q27010575-BF282474-070D-47B1-953F-4303ED097908 Q33753475-A11644EA-51D3-4914-8D6C-FF805778C0B2 Q34530533-9C80D8C2-B40B-4A3C-8740-1D9508E05F27 Q36955623-EAE3A86A-E926-4440-B129-4A57D88725E2 Q37190323-746285A7-7A33-42A2-8A94-A2C3056A6DBF Q37463639-40DE0ECB-A517-4882-B657-101D3E8CA3F0 Q37603804-74617F1E-431B-4444-94AF-EB07B66A95AB Q37667246-EF5C0118-45F8-4A9E-956E-5B43082DFA8F Q38004033-5EBCE42D-2396-455B-94EF-0EC1E991C34B Q38105006-D55AA2A6-FFB1-4457-B2DC-A717CD5020B5 Q38869424-64E798A0-3386-48F3-9808-8ACB90CA907A Q39480039-34931053-BB87-4C84-8064-524F2386F4BE Q40314416-9B37F8D7-FA65-4E49-9762-5542F41A14BD Q45859764-A08E6F16-D91A-45C8-BCB4-3A4D48652F85 Q46890290-DED359B8-DADD-4D2B-AB82-93FB39CF6A88 Q52720805-326FFE9A-6567-45C2-9AC2-C6F1347D38BB

P2860

Radiotherapy and "new" drugs-new side effects?

http://www.wikidata.org/entity/Q26861498

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Radiotherapy and "new" drugs-new side effects?

@ast

Radiotherapy and "new" drugs-new side effects?

@en

Radiotherapy and "new" drugs-new side effects?

@nl

type

label

Radiotherapy and "new" drugs-new side effects?

@ast

Radiotherapy and "new" drugs-new side effects?

@en

Radiotherapy and "new" drugs-new side effects?

@nl

prefLabel

Radiotherapy and "new" drugs-new side effects?

@ast

Radiotherapy and "new" drugs-new side effects?

@en

Radiotherapy and "new" drugs-new side effects?

@nl

P1433

Q26861498-C21B8C44-7ECE-4325-AE07-4B6ABE07EBB6

P1476

Q26861498-59B87EFE-3F76-497C-826C-5D9B2DA3885E

P2093

Q26861498-9A780A41-06AC-4CFE-BBB9-826D1207FA0E

Q26861498-A5D8E791-C734-4A66-A27A-56C4A277A01C

Q26861498-C55BA23E-20E0-481D-B187-17091D886832

Q26861498-DA57637A-6D94-44B4-9A1E-541E5FB63E0E

P275

Q26861498-711B2924-5F8E-4612-B721-4B5B0DC94A75

P2860

Q26861498-01063DED-911D-4B9B-AA1F-E040516C8D00

Q26861498-0113764B-44F5-49B9-BE48-7DCBE0BD953B

Q26861498-02D46EC2-29E6-4B6C-92D3-4536AD71670E

Q26861498-02E5CA8F-BB59-459B-AD3C-22443F9765CA

Q26861498-055C1283-B8B6-42C0-8F44-CCDE8C4D123A

Q26861498-082CE1D1-684B-4268-BB75-1DD79CE1534B

Q26861498-099C4B2B-EDFB-4B9D-913D-4BF5DCBF9805

Q26861498-0A808353-880B-4D0E-885E-96C9E6BD9642

Q26861498-0A9FDC13-BD35-4B57-9880-9611DBBF7D22

Q26861498-0CC2A17A-893E-42EC-9686-31D1FC3498EB

P2888

Q26861498-BA598EEF-933A-4C31-B03E-8699DDC0293A

P304

Q26861498-15C56505-3F3F-40F3-81F9-FABD75D08811

P31

Q26861498-E1A2F400-AAF7-4AFD-B71D-141014E0EEFE

Q26861498-EDA1D235-9FB9-4780-8038-E9DE6AF3E26B

P356

Q26861498-83917863-0D5C-4890-9D68-414282EC6D8F

P407

Q26861498-57DF6007-9326-4BEE-A8FF-2A65C3D53B42

P478

Q26861498-55B979FE-5AC9-4274-9780-47AE5A4573DF

P50

Q26861498-0A69D5FF-D12E-4DCB-A45D-7D0F71648D72

Q26861498-7865360A-63ED-437F-B67C-10398FE6DD11

P5008

Q26861498-8A78698E-E25C-40EA-84BA-A254B6E35798

P577

Q26861498-6FFE8C8C-5E5C-402A-93E5-D4B4DA980075

P5875

Q26861498-8DBE8053-16C4-4F47-AC34-1A74F919D3E1

P6179

Q26861498-474ACBAA-59E7-4A99-82B2-FA94AA999E9D

P698

Q26861498-8DF62296-2097-4004-9E36-4D15C5D6C1C7

P921

Q26861498-B8E73519-A3F6-42FD-A75E-314633021489

Q26861498-D4CA58CC-69EA-41A9-A696-1D3E67C5D251

P932

Q26861498-B006878B-2DAB-4C90-BD4C-D22492F9D60B

P356

1748-717X-6-177

P1433

Radiation Oncology

P1476

Radiotherapy and "new" drugs-new side effects?

@en

P2093

Claus Belka

http://www.w3.org/2001/XMLSchema#string

Cornelius Maihoefer

http://www.w3.org/2001/XMLSchema#string

Maximilian Niyazi

http://www.w3.org/2001/XMLSchema#string

Wilfried Budach

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411

Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177.

Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment.

Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells.

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).

P2888

1748-717x-6-177

P304

177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1748-717X-6-177

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Mechthild Krause

P5008

P577

2011-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51906446

http://www.w3.org/2001/XMLSchema#string

P6179

1038046569

http://www.w3.org/2001/XMLSchema#string

P698

22188921

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

3266653

http://www.w3.org/2001/XMLSchema#string